Polypharmacy in older patients with cancer

• Author(s): Ferraz Oliveira, Rita ; Afreixo, Vera ; Santos, João ; Mota, Priscilla ; Cruz, Agostinho ; Pimentel, Francisco
• Date: 2017
• Persistent ID: http://hdl.handle.net/10400.22/14455
• Origin: Repositório Científico do Instituto Politécnico do Porto
• Subject(s): Elderly patients; Older patients; Polypharmacy; Cancer; Chemotherapy
• Document Type: Conference object
• Language: English
• Contributor(s): REPOSITÓRIO P.PORTO

Description

Polypharmacy is associated with drug–drug interactions, adverse drug events, hospitalization, increased mortality and rising costs. Older cancer patients are potentially vulnerable to polypharmacy because cancer treatment often involves exposure to chemotherapy and other adjunctive or supportive medication.